| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10914897 | Molecular Oncology | 2013 | 9 Pages |
Abstract
⺠LPA-induced EGFR transactivation and its inhibition for ovarian cancer progression. ⺠EGFR aggravates ovarian cancer progression through proteolytic enzyme secretion. ⺠A Gi and G13/EGFR/Ras/Rho/ROCK signaling cascade for proteolytic enzyme secretion. ⺠Reseveratrol inhibits EGFR activation and ovarian cancer invasion. ⺠Resveratrol increases the therapeutic potential of an EGFR inhibitor.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Kang Jin Jeong, Kyung Hwa Cho, Nattapon Panupinthu, Hoon Kim, Jaeku Kang, Chang Gyo Park, Gordon B. Mills, Hoi Young Lee,